CARBOGEN AMCIS: Dishman Carbogen Amcis announces of change in CEO of Carbogen Amcis entities
Further, the company announced that Stephan Fritschi, currently serving as Chief Alliance Officer and deputy CEO, will assume the role of CEO, effective as of 01 April 2025.
Read full article »
CEO
CARBOGEN AMCIS is a provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries.
Read more